- Home
- AFCG vs YI Comparison
AFCG vs YI Comparison
Compare AFCG & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AFCG | YI |
|---|---|---|
| Founded | 2020 | 2010 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Retail-Drug Stores and Proprietary Stores |
| Sector | Real Estate | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.4M | 57.1M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AFCG | YI |
|---|---|---|
| Price | $3.06 | $5.79 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 280.8K | 12.4K |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | ★ 6.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $24,563,601.00 | N/A |
| Revenue This Year | $1,334.03 | N/A |
| Revenue Next Year | $17.33 | N/A |
| P/E Ratio | $5.87 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.06 | $2.48 |
| 52 Week High | $5.78 | $11.17 |
Technical Indicators
Market Signals| Indicator | AFCG | YI |
|---|---|---|
| Relative Strength Index (RSI) | 55.50 | 44.49 |
| Support Level | $2.74 | $5.33 |
| Resistance Level | $3.42 | $7.18 |
| Average True Range (ATR) | 0.21 | 0.47 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 46.78 | 44.62 |
Price Performance
Historical ComparisonAbout AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.